酞胺哌啶酮联合美法仑、泼尼松治疗多发性骨髓瘤疗效观察
出处
《浙江医学》
CAS
2004年第7期542-544,共3页
Zhejiang Medical Journal
参考文献8
-
1张之南.血液病诊断及疗效标准.第2版.北京:科学出版社,1998.373.
-
2Kees M,Dimou G,Sillaber C,et al. Low dose thalidomide in patients with relapsed or refractory multiple myeloma. Leuk Lymphoma,2003,44.(11): 1943.
-
3Rajkamar SV,Kyle RA. Thalidomide in the treatment of plasma cell malignancies. J Clin Onco,2001,19(16): 3593.
-
4Marriott JB,Muller G,Dalgleish AG. Thalidomide as an emerging immunotherapeutic agent. Immunology Today,1999,20(12):538.
-
5Peuckmann V,Fisch M,Bruera E. Potential novel uses of thalidomide. Drugs,2000,60(2): 273.
-
6Kumar S,Witzig TE,Dispenzieri A,et al. Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma. Leukemia,2004,18(3): 624.
-
7Hideshima T,Chauhan D,Shima D,et al. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cell to conventionary therapy. Blood,2000,96(9): 294.
-
8Isoardo G,Bergui M,Durelli L,et al. Thalidomide neuropathy:clinical,electrophysiological and neuroradiological features. Acta Neurol Scand,2004,109(3): 188.
-
1李西平,王曾礼,刘叙仪,王洁,蒋薇,张毅,刘元林.酞胺哌啶酮对耐顺铂人肺腺癌细胞系血管生成因子的影响[J].中华内科杂志,2002,41(7):481-483.
-
2王卉,江滨,刘开彦,邱镜滢,韩伟,陈欢,陆道培.酞胺哌啶酮治疗多发性骨髓瘤的临床观察[J].中华血液学杂志,2001,22(6):326-327. 被引量：6
-
3静雨.酞胺哌啶酮治疗骨髓瘤[J].国外医学情报,2001,22(5):36-37.
-
4田发青,李娟,唐玫琴,李举亨,成小慧,黄映彩,李惠卿.沙利度胺单药诱导急性单核细胞白血病完全缓解1例并文献复习[J].临床血液学杂志,2017,30(1):66-68.
-
5任洪军,杨静.酞胺哌啶酮治疗多发性骨髓瘤11例临床观察[J].承德医学院学报,2005,22(2):167-168.
-
6杨玮,张学进,赵毅,邓旻.反应停治疗多发性骨髓瘤8例疗效观察[J].浙江实用医学,2003,8(3):163-164.
-
7董秀娟,陈蕾,吴艳,赛亚,马东燕,赵晓武.酞胺哌啶酮治疗多发性骨髓瘤12例临床观察[J].青岛医药卫生,2007,39(3):183-185. 被引量：1
-
8李鸽.酞胺哌啶酮联合化疗治疗多发性骨髓瘤的临床观察[J].浙江临床医学,2003,5(2):126-126.
-
9李瑞玲.酞胺哌啶酮治疗难治性多发性骨髓瘤的效果观察[J].中国实用神经疾病杂志,2009,12(20):58-59.
-
10GAO Song YANG Xue-jun ZHANG Wen-gao JI Yan-wei PAN Qiang.Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro[J].Chinese Medical Journal,2009(11):1260-1266. 被引量：16
